Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LAE001
i
Other names:
LAE 001, LAE001, CFG920, CFG-920
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Laekna Therap, Novartis
Drug class:
CYP17A1 inhibitor, Aldosterone synthase inhibitor
Related drugs:
‹
abiraterone acetate (59)
abiraterone/niraparib (2)
abiraterone acetate (0)
AST-2970 (0)
ASP5541 (0)
INO-464 (0)
abiraterone acetate (59)
abiraterone/niraparib (2)
abiraterone acetate (0)
AST-2970 (0)
ASP5541 (0)
INO-464 (0)
›
Associations
News
Trials
Filter by
Latest
3ms
A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer (clinicaltrials.gov)
P1/2, N=33, Suspended, Laekna Limited | N=80 --> 33 | Trial completion date: Aug 2022 --> Jun 2025 | Unknown status --> Suspended | Trial primary completion date: Feb 2022 --> Oct 2023
3 months ago
Enrollment change • Trial completion date • Trial suspension • Trial primary completion date
|
LAE001
1year
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC (clinicaltrials.gov)
P1/2, N=74, Active, not recruiting, Laekna Limited | Recruiting --> Active, not recruiting
1 year ago
Enrollment closed
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PTEN (Phosphatase and tensin homolog)
|
docetaxel • prednisone • afuresertib (LAE002) • LAE001
over1year
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC (clinicaltrials.gov)
P1/2, N=74, Recruiting, Laekna Limited | Trial completion date: Oct 2022 --> Oct 2024 | Trial primary completion date: Sep 2022 --> Oct 2023
over 1 year ago
Trial completion date • Trial primary completion date • Metastases
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PTEN (Phosphatase and tensin homolog)
|
docetaxel • prednisone • afuresertib (LAE002) • LAE001
over2years
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC (clinicaltrials.gov)
P1/2, N=74, Recruiting, Laekna Limited | Trial completion date: Oct 2021 --> Oct 2022 | Trial primary completion date: Sep 2021 --> Sep 2022
over 2 years ago
Clinical • Trial completion date • Trial primary completion date
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PTEN (Phosphatase and tensin homolog)
|
docetaxel • prednisone • afuresertib (LAE002) • LAE001
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login